title: Investigations on the physiological controls of water and saline intake in C57BL/6 mice.
abstract: To examine the behavioral and neural control of body fluid homeostasis, water and saline intake of C57BL/6 mice was monitored under ad libitum conditions, after treatments that induce water or salt intake, and after ablation of the periventricular tissue of the anteroventral third ventricle (AV3V). Mice have nocturnal drinking that is most prevalent after the offset and before the onset of lights. When given ad libitum choice, C57BL/6 mice show no preference for saline over water at concentrations up to 0.9% NaCl and a progressive aversion to saline above that concentration. Systemic hypertonic saline, isoproterenol, and polyethylene glycol treatments are dipsogenic; however, systemic ANG II is not. Intracerebroventricular injections of both hypertonic saline and ANG II are dipsogenic, and diuretic treatment followed by a short period of sodium deprivation induces salt intake. After ablation of the AV3V, mice can be nursed to recovery from initial adipsia and, similar to rats, show chronic deficits to dipsogenic treatments. Taken together, the data indicate that mechanisms controlling thirst in response to cellular dehydration in C57BL/6 mice are similar to rats, but there are differences in the efficacy of extracellular dehydration-related mechanisms, especially for systemic ANG II, controlling thirst and salt appetite.
authors.affiliation: Department of Psychology, University of Iowa, Iowa City 52242, USA.
authors.forename: Ralph F
authors.initials: RF
authors.lastname: Johnson
authors.forename: Terry G
authors.initials: TG
authors.lastname: Beltz
authors.forename: Robert L
authors.initials: RL
authors.lastname: Thunhorst
authors.forename: Alan Kim
authors.initials: AK
authors.lastname: Johnson
mesh_terms: D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D020643:Anterior Thalamic Nuclei / Q000187:drug effects / Q000502:physiology; D001826:Body Fluids / Q000187:drug effects / Q000378:metabolism; D002216:Captopril / Q000494:pharmacology; D003681:Dehydration / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004327:Drinking Behavior / Q000187:drug effects / Q000502:physiology*; D006706:Homeostasis / Q000187:drug effects; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D012965:Sodium Chloride / Q000008:administration & dosage / Q000378:metabolism*; D013894:Thirst / Q000187:drug effects / Q000502:physiology; D014867:Water / Q000008:administration & dosage / Q000378:metabolism*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D014867:Water; D000804:Angiotensin II; D012965:Sodium Chloride; D002216:Captopril